BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder

The bromodomain adjacent to zinc finger 2B gene (BAZ2B) encodes a protein involved in chromatin remodeling. Loss of BAZ2B function has been postulated to cause neurodevelopmental disorders. To determine whether BAZ2B deficiency is likely to contribute to the pathogenesis of these disorders, we performed bioinformatics analyses that demonstrated a high level of functional convergence during fetal cortical development between BAZ2B and genes known to cause autism spectrum disorder (ASD) and neurodevelopmental disorder. We also found an excess of de novo BAZ2B loss‐of‐function variants in exome sequencing data from previously published cohorts of individuals with neurodevelopmental disorders. We subsequently identified seven additional individuals with heterozygous deletions, stop‐gain, or de novo missense variants affecting BAZ2B. All of these individuals have developmental delay (DD), intellectual disability (ID), and/or ASD. Taken together, our findings suggest that haploinsufficiency of BAZ2B causes a neurodevelopmental disorder, whose cardinal features include DD, ID, and ASD.

[1]  Lisa T. Emrick,et al.  Disruptive mutations in TANC2 define a neurodevelopmental syndrome associated with psychiatric disorders , 2019, Nature Communications.

[2]  Bin Zhou,et al.  Chromatin remodeling factor BAZ1A regulates cellular senescence in both cancer and normal cells. , 2019, Life sciences.

[3]  K. Tammimies Genetic mechanisms of regression in autism spectrum disorder , 2019, Neuroscience & Biobehavioral Reviews.

[4]  S. Ozonoff,et al.  Changing conceptualizations of regression: What prospective studies reveal about the onset of autism spectrum disorder , 2019, Neuroscience & Biobehavioral Reviews.

[5]  Ryan L. Collins,et al.  Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes , 2019, bioRxiv.

[6]  S. Kummerfeld,et al.  Non-canonical reader modules of BAZ1A promote recovery from DNA damage , 2017, Nature Communications.

[7]  Bradley P. Coe,et al.  Targeted sequencing identifies 91 neurodevelopmental disorder risk genes with autism and developmental disability biases , 2017, Nature Genetics.

[8]  Deciphering Developmental Disorders Study,et al.  Prevalence and architecture of de novo mutations in developmental disorders , 2017, Nature.

[9]  B. O’Roak,et al.  Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder , 2016, bioRxiv.

[10]  Raphael A. Bernier,et al.  denovo-db: a compendium of human de novo variants , 2016, Nucleic Acids Res..

[11]  L. Vissers,et al.  Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability , 2016, Nature Neuroscience.

[12]  L. Feuk,et al.  A Role for the Chromatin‐Remodeling Factor BAZ1A in Neurodevelopment , 2016, Human mutation.

[13]  K. Kosik,et al.  Haploinsufficiency of BAZ1B contributes to Williams syndrome through transcriptional dysregulation of neurodevelopmental pathways. , 2016, Human molecular genetics.

[14]  M. Daly,et al.  Interpreting de novo Variation in Human Disease Using denovolyzeR , 2015, Current protocols in human genetics.

[15]  D. Valle,et al.  GeneMatcher: A Matching Tool for Connecting Investigators with an Interest in the Same Gene , 2015, Human mutation.

[16]  Ayal B. Gussow,et al.  The Intolerance of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity , 2015, PLoS genetics.

[17]  R. Eils,et al.  BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence , 2014, Nature Genetics.

[18]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[19]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[20]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[21]  D. Goldstein,et al.  Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.

[22]  Bradley P. Coe,et al.  Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders , 2012, Science.

[23]  J. Kleinman,et al.  Spatiotemporal transcriptome of the human brain , 2011, Nature.

[24]  S. Knapp,et al.  Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery. , 2011, Molecular bioSystems.

[25]  C. Lord,et al.  The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors , 2010, Neuron.

[26]  Ming-Ming Zhou,et al.  Structural insights into selective histone H3 recognition by the human Polybromo bromodomain 2 , 2010, Cell Research.

[27]  B. Cairns,et al.  The biology of chromatin remodeling complexes. , 2009, Annual review of biochemistry.

[28]  Sharmila Banerjee-Basu,et al.  AutDB: a gene reference resource for autism research , 2008, Nucleic Acids Res..

[29]  Michael Q. Zhang,et al.  Combinatorial patterns of histone acetylations and methylations in the human genome , 2008, Nature Genetics.

[30]  Megan F. Cole,et al.  Genome-wide Map of Nucleosome Acetylation and Methylation in Yeast , 2005, Cell.

[31]  I. Vetter,et al.  ACF1 improves the effectiveness of nucleosome mobilization by ISWI through PHD–histone contacts , 2004, The EMBO journal.

[32]  S. Rogers Developmental regression in autism spectrum disorders. , 2004, Mental retardation and developmental disabilities research reviews.

[33]  J. Nezu,et al.  A novel family of bromodomain genes. , 2000, Genomics.